chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose, feel bad; 2nd dose, very short of breath; 2nd dose could not move arm; 2nd dose sweats; 2nd dose cold; 2nd dose, do not feel good at all; 2nd dose, feel like throwing up; 2nd dose, bad headache/terrible headache; 2nd dose, arm sore right after shot; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats) and FEELING COLD (2nd dose cold) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up), HEADACHE (2nd dose, bad headache/terrible headache) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Headache, at a dose of 2 tablets,every 4hrs. At the time of the report, FEELING ABNORMAL (2nd dose, feel bad), DYSPNOEA (2nd dose, very short of breath), VACCINATION SITE MOVEMENT IMPAIRMENT (2nd dose could not move arm), HYPERHIDROSIS (2nd dose sweats), FEELING COLD (2nd dose cold), VACCINATION COMPLICATION (2nd dose, do not feel good at all), NAUSEA (2nd dose, feel like throwing up) and PAIN IN EXTREMITY (2nd dose, arm sore right after shot) outcome was unknown and HEADACHE (2nd dose, bad headache/terrible headache) had not resolved.            Concomitant product use was not provided by the reporter.  Patient took 2 tablets of Advil every 4 hours, and the headache still didn't  go away.   This case was linked to MOD-2021-302196 (Patient Link).
Fever , chills, tireness, redness and swelling after 6 hours. took tylenol every 4 hours for 2 day, then starting taking 2 times daily.
Pt vaccinated and then felt lightheaded, diaphoretic, mild nausea. Vitals stable. Given Ondansetron 4mg PO. Patient still slightly lightheaded prior to leaving, but feeling better.
Standard soreness at sigh of injection, but woke up around 2:30am shaking. As if I was cold but didn?t not feel cold, checked my temperature and it was normal, shaking lasted about 30 minutes then stopped.
This spontaneous report as received from a medical assistant refers to 4 years child patient of unknown gender. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX was exposed to 46F for 1 hour, at worst. The patient received VARIVAX dose 0.5 ml, intramuscularly, lot J006358 expiry 23-MAY-2015, between 12-APR-2014 and 24-APR-2014. There was a site visit from local health department on an unspecified date. No adverse effects was reported. This is one of several reports from the same source. Additional information has been requested.
vasovagal episode with him turning pale, hypotension, bradycardia, dizziness, nausea.  Watched for 45 min and he was still feeling the same way, so sent to hospital
Muscle cramps, soreness, tingling in legs, slight lipming Muscle tenderness in arms Right eyelid drooping Joint pain
Information was received on 14-APR-2017 from a nurse regarding an unspecified number of patients. Medical history, concurrent conditions and concomitant medications were not reported. On an unspecified date (reported as between 20-MAR-2017 to 14-APR-2017 the patients were vaccinated with improperly stored doses of GARDASIL 9, (lot # M036059, expiration 03-JUN-2019); PEDVAXHIB, (lot # M045206 (expiration 27-JUN-2019); and ROTATEQ, (lot # M039434, expiration 24-MAY-2018) (doses not reported). Temperature: 47 degrees Fahrenheit to 77 degrees Fahrenheit; Time frame 8 hours; Was it administered: Yes; Previous temperature excursion: No; Was call because of a "data logger"?: Yes. No adverse events reported. No further information was reported. The action taken was not applicable and the outcome was unknown. Additional information has been requested.
2 days after 2nd dose I was very tired for a week and a half. Then i started feeling better but it came back and now for the last 3 or so weeks I have feel tired.  I have gone to get an ultrasound of my liver. Cardiologist suggestest ultrasound of my heart.  Increased heart rate. Increased weight gain. Fatigue.  **I do not know if the vaccine is the cause.
Very red arm at site of Dtap, mom will call if worse. Morning of 10/12 nickel size red, eve of 10/12 bigger, morn of 10/13 ~4in area of redness, warm, very itchy.
Pain & soreness on arm in area of vaccine for the last 5 weeks.  Hurt to raise arm over head, lift or carry objects.  Currently taking Aleve twice daily for 10 days.
This spontaneous report as received from a physician refers to an 8 years old male patient. The patient was vaccinated with the first dose of GARDASIL (lot number was unknown) (dose and route were not reported) on 12-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. The reporter stated that on 12-JUL-2012, GARDASIL was administered to the patient who was an 8 year old boy and there was no adverse reaction. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Patient reports that 10 days after receiving vaccine, he developed tingling sensation in his palms and soles of foot that extended to fingers and toes, followed by weakness in his LE. Patient reports no other symptoms. Patient was evaluated in inpatient setting, started on IVIG, and symptoms began to improve immediately after first dose.
Two 13 year olds received their first Moderna dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Two 13 year olds received their first Moderna dose) in a 13-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Two 13 year olds received their first Moderna dose). On 03-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Two 13 year olds received their first Moderna dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This reports includes 2 patients. Concomitant product information was not provided. Treatment information was not provided.
pt recvd vax 20OCT92 in afternoon & devel h/a beginning 21OCT92 in AM; itching to palms of hands, facial flush progressing to edema of tongue & lips & hives to entire body beninning approx 1700 hrs;
Patient was admitted to the hospital Oct. 17, 2021 for COVID-19 related symptoms. This is classified as a breakthrough case.
January 28: Soreness in right arm January 29: Soreness in right arm, fatigue February 4: Noticed soreness under right armpit/above right breast February 5: Continued soreness in same location. Upon closer inspection, a lump slightly smaller in diameter than a baseball was visible in the area of soreness (underneath right armpit). The lump was noticeable by touch as well, but did not feel hard. It felt swollen but still fleshy. February 12: The soreness from the lump has subsided, but the lump is still present. The lump feels slightly smaller in size.
67 year old female with PMH.  Presented to site for Moderna vaccine 2nd dose, w/ no acute discern at the time.  Patient reported shortness of breath, chest pain/discomfort, High BP SP vaccine administered.  GMS initiated ALS treatment. *Clinical Lead NOR Site Manager was notified until after the fact.* Initial examination on stretcher in back of ambulance - BP 210/106 --- blood sugar 120 ---- HR 146 At bedside in ER - BP 212/102 --- HR 126
Issues with her eye; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (Issues with her eye) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Corneal transplant on 22-Apr-2021. Concurrent medical conditions included Migraine. Concomitant products included SUMATRIPTAN (IMITREX [SUMATRIPTAN]) for Migraine, TRAZODONE, VERAPAMIL, EZETIMIBE and OMEPRAZOLE for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (Issues with her eye). The patient was treated with LOTEPREDNOL ETABONATE (LOTEMAX) on 22-Apr-2021 for Adverse event, at a dose of UNK, q6h and BESIFLOXACIN HYDROCHLORIDE (BESIVANCE) ongoing from 22-Apr-2021 for Adverse event, at a dose of 3 times a day (antibiotic). At the time of the report, EYE DISORDER (Issues with her eye) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was reported to be scheduled for second dose of vaccine on 27-APR-2021.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up information contained no new information.
Dizziness, lightheaded, near syncope, low grade fever Given IV Fluids.
Initial information was received from a health care professional on 15 December 2009. A male infant received a transplacental dose of FLUZONE SV (lot not reported) on 30 October 2008 via his 32-year-old mother. His mother's last menstrual period was 29 June 2008, and her medical history included chlamydia (2006), tobacco use (stopped in May 2008), BMI less than 19 and anemia and postpartum hemorrhage requiring blood transfusion in a previous pregnancy. She had a history of one previous full-term birth, and one elective abortion. On 03 November 2008, four days post-vaccination, the patient's mother experienced optic neuritis, for which she was hospitalized and treated with intravenous steroids. On 31 January 2009, at 30.5 weeks gestation, the patient's mother experienced premature rupture of membranes; she was hospitalized and treated with VISTARIL, terbutaline, and betamethasone. At 31 weeks, 1 day gestation the patient's mother developed a fever of 100.3 with mild uterine tenderness. Findings were suspicious for chorioamnionitis, and so the recommendation was made to proceed with a primary C-section. On 03 February 2009 the patient was delivered via uncomplicated cesarean section, with Apgar scores of 8/10 at one minute and 9/10 at 5 minutes. He weighed 3 pounds, 4 ounces, and had no congenital anomalies. The patient's mother was discharged from the hospital on 07 February 2009, and the patient remained in the NICU at that time. Outcome was not reported. This case pertains to the infant; information for the mother can be found in case number 2009-04794. Documents held by sender: Office and hospital records.
Received Moderna vaccine on 1/26/2021 in left deltoid.  On 1/28/2021 an inflamed area noted to left arm that is warm to touch, tender, and lumpy.  100.0 temp noted and tylenol administered.   1/28/2021 APN and Doctor saw patient here at the facility for concerns of possible cellulitis and new orders received to circle area and notify doctor of increase in redness or any changes in condition, ice to left arm every 4 hours, and one time dose of benadryl allergy liquid.  Concerned that patient may not have received the full dose of the Moderna vaccine as it appears that the injection was given too low that muscle may have been missed. Tylenol every 4 hours as needed is also ordered for discomfort . Awaiting to hear back on guidance as to if another dose needs to be given.   Continuing to monitor at this time.
headaches; temp 99.4; neckache; tiredness; feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 18Feb2021 at 02:15 (at the age of 66-years-old) in the left arm as a single dose for COVID-19 immunisation. Medical history included heart transplant on an unspecified date, immunosuppressed from an unspecified date and ongoing and COVID-19 in Jul2020. The patient stated that "heart transplant most significant but others". Concomitant medications (other medications taken in two weeks) included tacrolimus, mycophenolate mofetil (MYCOPHENOLATE), pravastatin and lisinopril, all taken for unspecified indications on unspecified dates. The patient did not receive another vaccine within 4 weeks prior to the COVID-19 vaccine. The patient previously received atorvastatin (LIPITOR) and experienced allergy. On 18Feb2021 at 06:00 the patient experienced headaches, temp 99.4, neckache, tiredness and feeling unwell. The patient reported that he was immunosuppressed and for him a 1 degree increase in temperature was significant. He stated that he was diagnosed with COVID-19 at the end of July of 2020 and had subsequently recovered. These were new symptoms. The patient did not receive treatment for the events. The clinical outcomes of the events headaches, temp 99.4, neckache, tiredness and feeling unwell were all not recovered/not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
In September 2022 my breakthrough COVID-19 infection started with sore throat then a cough that was painful. I had a fever for about 48 hours that remained low-grade as well as chest congestion.   At Urgent Care I was prescribed Paxlovid and took that for 5 days.  The cough remained for two weeks.
13 days after injection, patient developed low-grade fever 100.3 and localized erythema, edema, warmth, and pain at injection site. Suspect delayed vaccine reaction.
Pt states his fingers became tingly and itchy about an hour after vaccine administration.  He said he waited to see if it would go away and symptoms subsided about 3 hours after onset.
Patient was being administered the Meningococcal B. vaccine when I saw patient leaning backwards slowly. I supported patients fall. I called provider to assist me with patient. Patient tensed / unresponsive for a good 20 seconds. -patient observed
Pfizer-BioNTech COVID-19 Vaccine: at annual wellness exam seven days after vaccination patient reports headache, fatigue, vision changes, and seeing people who are not there. Patient atrributes symptoms to immunization. Vital signs within normal ranges. No rash, dizziness, lightheadedness. Patient will follow-up with neuro-ophthamology.
Temperature of 104F for 3 hrs Rt arm swollen. Shaking when asleep noted by guest lasted for 30 sec or less.  Other children in family have virus.
arthritis; SICK; Diarrhea; Vomiting; Pain at injection site; Ache; Weak; Tired; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (SICK), DIARRHOEA (Diarrhea), VOMITING (Vomiting), INJECTION SITE PAIN (Pain at injection site) and PAIN (Ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced ILLNESS (SICK), VOMITING (Vomiting), INJECTION SITE PAIN (Pain at injection site), PAIN (Ache), ASTHENIA (Weak) and FATIGUE (Tired). 04-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). On 22-Feb-2021, the patient experienced ARTHRITIS (arthritis). At the time of the report, ILLNESS (SICK) and FATIGUE (Tired) had not resolved and DIARRHOEA (Diarrhea), VOMITING (Vomiting), INJECTION SITE PAIN (Pain at injection site), PAIN (Ache), ASTHENIA (Weak) and ARTHRITIS (arthritis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. Treatment medications were not provided by reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: Follow up received on 22-FEB-2021 , and added event whole body is inflamed with arthritis.
Information has been received from a nurse practitioner concerning a female who was vaccinated with a nurse practitioner concerning a female who was vaccinated with a dose of RECOMBIVAX HB (lot # not provided) (manufacturer unknown).  Subsequently the patient experienced an allergic reaction.  The patient sought unspecified medical attention.  Therapy with RECOMBIVAX HB was discontinued.  Subsequently, the patient recovered.  There was no product quality complaint.  No further information is available.
Restless legs; Sweat; headache; Low grade fever; Chills; This is a spontaneous report from a contactable consumer or other non hcp received by Pfizer. Reference ID: NUS2021US049295_NC. A 44-years-old female patient started to receive unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: Not reported) via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, patient experienced headache, restless legs, low grade fever, sweat and chills. The reporter considered the events as non-serious. The patient received treatment for headache with Tylenol and for about 12 hours after event resolved. The outcome of event headache was recovered on an unspecified date while for the restless legs, low grade fever, sweat and chills was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
About 10 minutes post injection, the pt. experienced dizziness and tingling in her arms and legs.  The dizziness lasted for about 40 minutes and the tingling lasted about 10 minutes.
Pt states approximately 10 minutes after the shot began having some throat tightness.  Slightly hypertensive, denies fevers, chills, rash, or itching.  Pt told staff that she throat was feeling tighter, epi pen was administered and 911 was called.  EMS was called and they administered 50 of IV benadryl.   Pt was taken to local ED.  Upon arrival of ED, pt stated she felt much better, denied any lip/tongue swelling or shortness of breath.  Pt was observed for 2 hours in the ED with no symptoms, pt feeling much better, and was released.  Discussion will be had as to whether pt should receive 2nd dose.
swollen lymph nodes in armpit and pectoral region of chest on same side as booster innoculation.  Went away in about a week No swelling on opposite side.
Moderna COVID -19 vaccine given to 12 year old- outside of age approved EUA
Itchy injection site, entire injection site red (about 2in diameter) this was the same area of the arm that was swollen and painful in the 24-48 hrs following the injection but a week later. Injection site is still itchy 2 weeks after and slightly swollen, but no longer red.
Fever 100.1, extreme body aches, severe frontal headache starting at 9pm the day after vaccination and lasting 12 hours.  Symptoms slowly are resolving but not fully resolved as of 2:30pm Jan 31.
Joint pain, headaches, nausea, diarrhea, muscle aches, pain and rash at injection site, tiredness. Oral Tylenol, fluids, and bed rest. On going, headaches lessened, no need of medical intervention at this point.
12/11/21 - Developed dry cough 12/14/21 - Cough worsens, chills, fever, body aches and headache 12/20/21 - Cough, chills, body aches and headache continue - seen by Primary Care Provider. Assumed metapneumovirus as child had tested positive with similar symptoms on 12/13/21. Given Prednisone and Azithromycin for bronchitis. Tested negative for COVID and Influenza. 12/23/21 - Cough continues to worsen, now with shortness of breath, continuous headache, and  significant fatigue. Seen by Primary Care Provider again, chest Xray completed, given Rocephin by injection and Solumedrol by injection. Lung base fields are diminished bilaterally by auscultation. Also given prescription for Augmentin for cough with chest congestion and shortness of breath. Given Albuterol nebulizer treatments and incentive spirometer to attempt to prevent pneumonia. Labs also drawn - CBC, CMP. Biofire panel positive for metapneumovirus. Negative for all others.  12/25/21 - Started Augmentin as cough continues to worsen despite Albuterol treatments and use of incentive spirometer.
Patient states she had redness that progressed on the Left upper arm starting on 10-24-18 after receiving vaccine on 10-23-18. Patient also c/o pain at the injection site.
Approx. 5 minutes, post vax of Prevnar, baby had red (small) blotches around nose and in hair line. No other symptoms noted. Normal temperature. The MD states "hives".
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 026L20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jun-2021. On 05-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant). On 03-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Got vaccine while Pregnant) had resolved. No Concomitant medications were  reported. No treatment information was provided.
I sneezed about 3-4 times after 3pm -7pm, and around 10:30pm 3-4 consecutive sneezes.   11pm -11:30pm-- one hive at injection site with itching on both arms, face, nose, inside of ears,, legs, back, hands and feet along with sneezing after almost 11 hours after injection.  It wasn't a frenzy itch where you are scratching all at once.  I took 25mg of Benadryl ,around 11:45pm  or midnight. Attempted to reach out to hospital, who placed vaccine with no success. 1:00am, I took another 25mg of Benadryl because the inside of my ears were still itching, but most of the other itching had stopped.  I reached out to my own PCP and was instructed to take my Epipen with me for the second dose.  It has been 3 days, and my nose is still itching and I have sneezed 6 times today. *****I normal don't sneeze since taking allergy shots years ago.******
dizziness, nausea, vomiting sx lessened over 48 hrs; treated w/rest, pepto bismol, APAP;
Fever of 100.7, severe headache, body aches, chills, flu like symptoms and arm pain at injection site for about 24 hours
Had 2nd vaccine at 1pm yesterday (01/05).  8pm started to had fatigue, body ache.  At 10pm got worse severe headache, fatigue, bodyache, 99-100.6. 10am this morning (01/06).  Headache was severe that staff had to take medicine and could not sleep well.